The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel.

CONCLUSION: This study revealed that EGFR mutation status and BM might be predictive or prognostic factors for PFS.
PMID: 32464632 [PubMed - as supplied by publisher]

Source: Oncology - May 27, 2020 Category: Cancer & Oncology Authors: Furuya N, Ito K, Sakaguchi T, Hida N, Kakinuma K, Morikawa K, Inoue T, Komase Y, Hataji O, Mineshita M Tags: Oncology Source Type: research